市場調查報告書
商品編碼
958125

實驗室自動化系統的全球市場

Laboratory Automation Systems

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 130 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球實驗室自動化系統的市場規模在分析期間(2020年∼2027年)預計將以4.8%的年複合成長率增長,從2020年的46億美元到2027年達到64億美元。本報告分析市場區隔之一的臨床部門在分析期間結束前預測將以4.9%的年率增長,達到41億美元。

本報告提供全球實驗室自動化系統市場的相關調查,市場佔有率,趨勢和預測,成長要素,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

調查對象企業範例

  • Abbott Diagnostics
  • Agilent Technologies, Inc.
  • Aurora Biomed, Inc.
  • Becton, Dickinson and Company
  • Becton, Dickinson and Company
  • bioMerieux SA
  • BioTek Instruments, Inc.
  • Brooks Automation, Inc.
  • Cerner Corporation
  • Danaher Corporation
  • Eppendorf AG
  • F. Hoffmann-La Roche AG
  • LabVantage Solutions, Inc.
  • LabWare, Inc.
  • Olympus Corporation
  • PerkinElmer, Inc.
  • QIAGEN NV
  • Sartorius Stedim Biotech SA
  • Siemens Healthineers
  • SOTAX AG
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.

目錄

I. 簡介,調查手法,調查範圍

II. 摘要整理

  • 市場概要
    • 競爭的市場佔有率
    • 競爭的市場佔有率方案
    • Covid-19的影響和即將到來的全球景氣衰退
  • 主要企業
  • 趨勢與成長要素
  • 全球市場預測

III. 市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 其他地區

IV. 競爭

  • 企業簡介:46公司
目錄
Product Code: MCP12921

Abstract:

Global Laboratory Automation Systems Market to Reach $6.4 Billion by 2027

Amid the COVID-19 crisis, the global market for Laboratory Automation Systems estimated at US$4.6 Billion in the year 2020, is projected to reach a revised size of US$6.4 Billion by 2027, growing at aCAGR of 4.8% over the period 2020-2027. Clinical, one of the segments analyzed in the report, is projected to record 4.9% CAGR and reach US$4.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drug Discovery segment is readjusted to a revised 4.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 4.5% CAGR

The Laboratory Automation Systems market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2027 trailing a CAGR of 4.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Select Competitors (Total 46 Featured) -

  • Abbott Diagnostics
  • Agilent Technologies, Inc.
  • Aurora Biomed, Inc.
  • Becton, Dickinson and Company
  • Becton, Dickinson and Company
  • bioMerieux SA
  • BioTek Instruments, Inc.
  • Brooks Automation, Inc.
  • Cerner Corporation
  • Danaher Corporation
  • Eppendorf AG
  • F. Hoffmann-La Roche AG
  • LabVantage Solutions, Inc.
  • LabWare, Inc.
  • Olympus Corporation
  • PerkinElmer, Inc.
  • QIAGEN NV
  • Sartorius Stedim Biotech SA
  • Siemens Healthineers
  • SOTAX AG
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Laboratory Automation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Laboratory Automation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Laboratory Automation Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 10: USA Current & Future Analysis for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 11: USA Historic Review for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: USA 15-Year Perspective for Laboratory Automation Systems by End-Use - Percentage Breakdown of Value Sales for Clinical and Drug Discovery for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 13: Canada Current & Future Analysis for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 14: Canada Historic Review for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: Canada 15-Year Perspective for Laboratory Automation Systems by End-Use - Percentage Breakdown of Value Sales for Clinical and Drug Discovery for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 16: Japan Current & Future Analysis for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 17: Japan Historic Review for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: Japan 15-Year Perspective for Laboratory Automation Systems by End-Use - Percentage Breakdown of Value Sales for Clinical and Drug Discovery for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 19: China Current & Future Analysis for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 20: China Historic Review for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: China 15-Year Perspective for Laboratory Automation Systems by End-Use - Percentage Breakdown of Value Sales for Clinical and Drug Discovery for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 22: Europe Current & Future Analysis for Laboratory Automation Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 23: Europe Historic Review for Laboratory Automation Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: Europe 15-Year Perspective for Laboratory Automation Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 25: Europe Current & Future Analysis for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: Europe Historic Review for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: Europe 15-Year Perspective for Laboratory Automation Systems by End-Use - Percentage Breakdown of Value Sales for Clinical and Drug Discovery for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 28: France Current & Future Analysis for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: France Historic Review for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: France 15-Year Perspective for Laboratory Automation Systems by End-Use - Percentage Breakdown of Value Sales for Clinical and Drug Discovery for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 31: Germany Current & Future Analysis for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Germany Historic Review for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: Germany 15-Year Perspective for Laboratory Automation Systems by End-Use - Percentage Breakdown of Value Sales for Clinical and Drug Discovery for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 34: Italy Current & Future Analysis for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Italy Historic Review for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Italy 15-Year Perspective for Laboratory Automation Systems by End-Use - Percentage Breakdown of Value Sales for Clinical and Drug Discovery for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 37: UK Current & Future Analysis for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: UK Historic Review for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: UK 15-Year Perspective for Laboratory Automation Systems by End-Use - Percentage Breakdown of Value Sales for Clinical and Drug Discovery for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 40: Rest of Europe Current & Future Analysis for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Rest of Europe Historic Review for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: Rest of Europe 15-Year Perspective for Laboratory Automation Systems by End-Use - Percentage Breakdown of Value Sales for Clinical and Drug Discovery for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 43: Asia-Pacific Current & Future Analysis for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Asia-Pacific Historic Review for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: Asia-Pacific 15-Year Perspective for Laboratory Automation Systems by End-Use - Percentage Breakdown of Value Sales for Clinical and Drug Discovery for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 46: Rest of World Current & Future Analysis for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Rest of World Historic Review for Laboratory Automation Systems by End-Use - Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: Rest of World 15-Year Perspective for Laboratory Automation Systems by End-Use - Percentage Breakdown of Value Sales for Clinical and Drug Discovery for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 46